Stockholders' Equity - CEO Performance Award - Additional Information (Details) $ / shares in Units, $ in Thousands			3 Months Ended	58 Months Ended
	Mar. 28, 2023 tranche $ / shares	May 24, 2018 USD ($) item tranche shares	Mar. 31, 2023 USD ($) shares	Mar. 31, 2023 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Market capitalization goal for such tranche		$ 2,500,000
Market capitalization goal increment		$ 1,000,000
Recorded share-based compensation expense				$ 246,000
Number of awards expected to vest | shares			500,000	500,000
Revenue goal number 1			$ 710,058	$ 710,058
Revenue goal number 2			860,058	860,058
Revenue goal number 3			1,010,058	1,010,058
Revenue goal number 4			1,210,058	1,210,058
Revenue goal number 5			1,410,058	1,410,058
Revenue goal number 6			1,610,058	1,610,058
Revenue goal number 7			1,810,058	1,810,058
Revenue goal number 8			2,010,058	2,010,058
Adjusted EBITDA goal number 1			125,000	125,000
Adjusted EBITDA goal number 2			155,000	155,000
Adjusted EBITDA goal number 3			175,000	175,000
Adjusted EBITDA goal number 4			190,000	190,000
Adjusted EBITDA goal number 5			200,000	200,000
Adjusted EBITDA goal number 6			210,000	210,000
Adjusted EBITDA goal number 7			220,000	220,000
Adjusted EBITDA goal number 8			$ 230,000	230,000
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares authorized (in shares) | shares		6,365,856
Number of options vested | shares			5,800,000
Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of vesting tranches of share-based awards | tranche		12
Vesting period		10 years
Number of performance goals, revenue | item		8
Number of performance goals, adjusted EBITDA | item		8
Chief Executive Officer | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of vesting tranches of share-based awards | tranche	10
Outstanding percentage of common stock	0.50%
Weighted average exercise price (in dollars per share) | $ / shares	$ 218.59
Unrecognized stock-based compensation expense			$ 0	$ 0